Authors

Mark Woodward

PhD, FMedSci, FAHMS, FESC, Chair of Statistics, Epidemiology and Women’s Health, The George Institute for Global Health, Imperial College London, London, UK; Professor of Medical Statistics, The George Institute for Global Health, University of New South Wales, Sydney, NSW

Risk treatment thresholds for initiating cardiovascular disease pharmacotherapy: Synthesis of international evidence to support guideline recommendations

Evidence-informed guideline recommendations on risk treatment thresholds for initiating blood pressure- and lipid-lowering therapy for cardiovascular disease primary prevention is presented.